FDA device listing

HemosIL AcuStar Anti-B2 Glycoprotein-I IgG,HemosIL AcuStar Anti-B2 Glycoprotein-I IgG Controls,HemosIL AcuStar Anti-B2…

FDA device listing 1891020754 · Instrumentation Laboratory Co.

Key facts

Proprietary names HemosIL AcuStar Anti-B2 Glycoprotein-I IgG,HemosIL AcuStar Anti-B2 Glycoprotein-I IgG Controls,HemosIL AcuStar Anti-B2 Glycoprotein-I IgM,HemosIL AcuStar Anti-B2 Glycoprotein-I IgM Controls
Owner/operator Instrumentation Laboratory Co.
Owner/operator number 1217183
Premarket submissions K091556
Product codes JJX, MSV
Device names JJX - Single (Specified) Analyte Controls (Assayed And Unassayed), MSV - System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi)
Device class Class I, Class II
Classification regulations (21 CFR) 862.1660, 866.5660
Review panels Clinical Chemistry, Immunology
Registered establishments INSTRUMENTATION LABORATORY CO., INSTRUMENTATION LABORATORY CO. - Devens
Establishment registrations 1217183, 3037000637
FEI numbers 1217183, 3037000637
Establishment operations Repackager/Relabeler, Specification Developer
Registration valid through 2026

At a glance

  • 1–9 Registered establishments listing this device
  • 10–99 UDI devices (GUDID) under the same submission
  • 1–9 Device listings citing the same submission
  • Yes Premarket submission listed

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA device listings

Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.

Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database

Browse all FDA device listings